Retraction

Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference

Citations (12)

12
Total Citations
0
Post-Retraction
11
Pre-Retraction
1
Same Day
Retraction: Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference
Unknown Authors
PLoS ONE Open Access
Published: Apr 2025
Same day as retraction
Expression of Concern: Specific Inhibition of Tumor Cells by Oncogenic EGFR Specific Silencing by RNA interference
Unknown Authors
PLoS ONE Open Access
Published: Dec 2024
1 citation
109 days before retraction
Paper citing Specific inhibition of tumor cells by oncogenic EG...
Unknown Authors
Unknown Journal
Published: Oct 2024
182 days before retraction
Anti-TGF-β1 aptamer enhances therapeutic effect of tyrosine kinase inhibitor, gefitinib, on non-small cell lung cancer in xenograft model
Masaki Takahashi, Yoshifumi Hashimoto, Yoshikazu Nakamura
Molecular Therapy — Nucleic Acids Open Access
Published: Jun 2022
10 citations
1007 days before retraction
Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy
Showket Hussain, Sonam Tulsyan, Sajad Ahmad Dar et al. (8 authors)
Seminars in Cancer Biology
Published: Jun 2021
32 citations
1375 days before retraction
NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells
Masashi Fukuoka, Katsuji Yoshioka, Hirohiko Hohjoh
PLoS ONE Open Access
Published: Aug 2018
20 citations
2433 days before retraction
Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs
Fang Liu, Chunfang Wang, Yuantao Gao et al. (10 authors)
Molecular Diagnosis & Therapy
Published: Jun 2018
36 citations
2477 days before retraction
Neighbors' death is required for surviving human adenocarcinoma PC-9 cells in an early stage of gefitinib treatment
Masaki Takahashi, Masashi Fukuoka, Katsuji Yoshioka et al. (4 authors)
Biochemical and Biophysical Research Communications
Published: Sep 2016
3 citations
3115 days before retraction
Delivery strategies and potential targets for siRNA in major cancer types
Sang Jin Lee, Min Ju Kim, Ick Chan Kwon et al. (4 authors)
Advanced Drug Delivery Reviews Open Access
Published: May 2016
131 citations
3227 days before retraction
Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
Delphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos et al. (4 authors)
Current Gene Therapy Open Access
Published: Aug 2015
26 citations
3507 days before retraction
Non-coding RNAs in lung cancer
Biagio Ricciuti, Carmen Mecca, Lucio Crinò et al. (6 authors)
Oncoscience Open Access
Published: Nov 2014
36 citations
3790 days before retraction
Paper citing Specific inhibition of tumor cells by oncogenic EG...
Unknown Authors
Unknown Journal
Published: Dec 2013
4138 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #64868
Dec 13, 2024
Expression of concern
Quick Stats
Total Citations: 12
Years Since Retraction: <1 year
Open Access: Yes
Last Checked: Jul 23, 2025